10/18/2023 0 Comments Blueprint medicine stock priceBenzinga does not provide investment advice. Read More: HP, Alphabet And 2 Other Stocks Insiders Are Selling SVB Leerink downgraded Blueprint Medicines from Market Perform to Underperform and lowered the price target from $48 to $43. Following the earnings report the stock price went down -15.341.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |